Global pharmaceutical company Eli Lilly & Co. announced plans to enlarge the scope of its manufacturing plant under construction in the Raleigh-Durham, North Carolina, area because of the rising popularity of its diabetes drugs.
Eli Lilly To Boost Size of North Carolina Plant To Meet Increased Demand for Diabetes Drug
Pharmaceutical Giant Expands Investment to $920 Million for North Carolina Drug Manufacturing Facility
By Andy Peters
CoStar News
January 24, 2023 | 7:59 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Eli Lilly Site
2242 Northeast Creek Pky, Durham, NC
- Grounds at Concord
2321 Concord Pkw S, Concord, NC
- Companies
- Lilly
Manufacturing